ta174 | R Documentation |
A dataset containing the data used for NICE TA174, as made publicly available as part of the supplementary material for Williams et al (2017). Medical Decision Making, 37;427-439.
ta174
A tibble with 810 rows and 8 variables:
A numeric patient identifier
The treatment indicator. 1=rituximab in combination with fludarabine andcyclophosphamide (RFC); 0=fludarabine and cyclo-phosphamide alone (FC)
An indicator to describe whether the patient has experience a progression
An indicator to describe whether the patient has experience death
The observed time at progression, or the time at which the patient has been censored; measured in months
The observed time at death, or the time at which the patient has been censored; measured in months
The observed time at progression, or the time at which the patient has been censored; measured in years
The observed time at death, or the time at which the patient has been censored; measured in years
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.